title: Potentiation of vincristine cytotoxicity by rubiginone B1 and piperafizine A in human Moser and K562 cells--mode of action.
authors.affiliation: Bristol-Myers Squibb Research Institute, Tokyo, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Ogasawara
authors.forename: M
authors.initials: M
authors.lastname: Hasegawa
authors.forename: Y
authors.initials: Y
authors.lastname: Hamagishi
authors.forename: H
authors.initials: H
authors.lastname: Kamei
authors.forename: T
authors.initials: T
authors.lastname: Oki
mesh_terms: D000880:Anthraquinones / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002277:Carcinoma; D015179:Colorectal Neoplasms; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D006801:Humans; D007938:Leukemia; D010879:Piperazines / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D014750:Vincristine / Q000494:pharmacology*; D000095602:Angucyclines and Angucyclinones
chemical_list: D000880:Anthraquinones; D000900:Anti-Bacterial Agents; D010879:Piperazines; D014750:Vincristine; C073563:rubiginone B1; D000095602:Angucyclines and Angucyclinones; C066103:piperafizine A